Clinical trial
Patterns of Care and Clinical Outcomes of Patients With Advanced Non-small Cell Lung Cancer (NSCLC) With EGFR Exon 20 Insertion Mutations
NCT05207423 is registered in ClinicalTrials.gov with Takeda as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Patterns of Care and Clinical Outcomes of Patients With Advanced Non-small Cell Lung Cancer (NSCLC) With EGFR Exon 20 Insertion Mutations
- Lead sponsor
- Takeda
- Phase
- Observational
- Overall status
- Completed
- Start date
- October 3, 2022
- Completion date
- February 13, 2023
- Enrollment
- 179 (actual)
- Sites
- 30
Conditions
As the registry lists them; a condition with its own page is linked.
non-small cell lung cancer (nsclc)